Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genetic Tech Spn ADR (NQ: GENE )

2.310 -0.010 (-0.43%)
Streaming Delayed Price Updated: 9:58 AM EDT, May 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Genetic Tech Spn ADR

< Previous 1 2 Next >
Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
From Genetic Technologies Ltd
Via GlobeNewswire
New Publication Validates geneType for Melanoma Risk Assessment
From Genetic Technologies Ltd
Via GlobeNewswire
Quarterly Business Update – March 2023
Driving growth, Expanded Multi-Test Panel and Publications Validating Clinical Utility of geneType 
From Genetic Technologies Ltd
Via GlobeNewswire
Publication Validates geneType Prostate Cancer Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation
From Genetic Technologies Ltd
Via GlobeNewswire
Back-to-back Studies Validate geneType Breast Cancer Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
New Publication Highlights geneType’s Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Announces $5 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer
From Genetic Technologies Ltd
Via GlobeNewswire
GTG to form Strategic Alliance with global testing leader QIAGEN
From Genetic Technologies Ltd
Via GlobeNewswire
Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Provides Business Update
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes
From Genetic Technologies Ltd
Via GlobeNewswire
Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
From Genetic Technologies Ltd
Via GlobeNewswire
Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
From Genetic Technologies Ltd
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.